Advertisement

International Urology and Nephrology

, Volume 26, Issue 1, pp 43–51 | Cite as

Bladder cancer following prostate cancer—An analysis of risk factors

  • H. E. H. Wegner
  • T. Meier
  • R. Klän
  • K.-P. Dieckmann
Article

Abstract

Between 1969 and 1988, 1421 men had been treated for primary adenocarcinoma of the prostate. In 14 cases subsequent primary bladder cancer was observed, as compared to 5.98 cases to be expected, thus constituting a relative risk of 2.34. Seven of these cases developed synchronously (within 6 months), with a range of up to 10 years. Aetiologically, cigarette smoking was detected as the single most important denominator, whereas family history was positive for malignancy in only two cases.

Keywords

Bladder Cancer Transitional Cell Carcinoma International Urology Urothelial Cancer Primary Adenocarcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Warren, S., Gates, O.: Multiple primary malignant tumours—A survey of the literature and statistical study.Am. J. Cancer, 16, 1358 (1932).Google Scholar
  2. 2.
    Bailar, J. C.: The incidence of independent tumors among uterine cancer patients.Cancer, 7, 842 (1963).CrossRefGoogle Scholar
  3. 3.
    Bordin, G. M., Key, C. R., McQuade, C. E., Kuvirt, D. M., Hughes, W. H., Brylinski, D. A.: Multiple primary cancers, relative risk in New Mexico's triethnic population.Cancer, 40, 1793 (1977).PubMedCrossRefGoogle Scholar
  4. 4.
    Saarland Tumor Registry: Jahresbericht des Saarländischen Krebsregisters, No. 139 (1987).Google Scholar
  5. 5.
    Axtell, L. M.: Cancer patient survival, report No. 5. A report from the Cancer Surveillance, Epidemiology and End Results (SEER) program, U.S. Department of Health, Education and Welfare, Public Health Service, National Institute of Health, National Cancer Institute, Bethesda, Maryland DHEW Publication No. (NIH) 77-992 (1976).Google Scholar
  6. 6.
    Der Senator für Gesundheit, Berlin.Google Scholar
  7. 7.
    Rotes, Kreuz Deutschland: Der Blutspendedienst informiert. Brochüre des DRK, 1988.Google Scholar
  8. 8.
    Dohm, G.: Le carcinome urothelial de la prostate avec ou sans implication de la vessie.J. Urol. (Paris),94, 397 (1988).Google Scholar
  9. 9.
    Hardeman, S. W., Perry, A., Soloway, M. S.: Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.J. Urol., 140, 298 (1988).Google Scholar
  10. 10.
    Reese, J. H., Freiha, F. S., Gelb, A. B., Lum, B. L., Torti, F. M.: Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy.J. Urol., 147, 92 (1992).PubMedGoogle Scholar
  11. 11.
    Dieckmann, K. P., Wegner, H. E. H.: Multiple primäre Neoplasien in urologischen Krankengut.Aktuel. Urol., 22, 315 (1991).CrossRefGoogle Scholar
  12. 12.
    Matzkin, H., Braf, Z.: Multiple primary neoplasms in the genitourinary tract, occurrence and etiology.J. Urol., 142, 1 (1989).PubMedGoogle Scholar
  13. 13.
    Haddow, J., Boyd, J. F., Graham, A. C.: Multiple primary neoplasms in the western hospital region, Scotland: A survey based on cancer registration data.Scot. Med. J., 17, 143 (1972).PubMedGoogle Scholar
  14. 14.
    Warren, S., Gates, O.: Cancer of the skin in relation to multiple malignant growth.J.A.M.A., 115, 1705 (1940).Google Scholar
  15. 15.
    Kabalin, J. N., McNeal, J. E., Price, H. M., Freiha, F. S., Stamey, T. A.: Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: Incidence, histology, and morphometric observations.J. Urol., 141, 1091 (1989).PubMedGoogle Scholar
  16. 16.
    Pritchett, T. R., Moreno, J., Warner, N. E., Lieskowsky, G., Nichols, P. W., Cook, B. A., Skinner, D. G.: Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder.J. Urol., 139, 1214 (1988).PubMedGoogle Scholar
  17. 17.
    Winfield, H. N., Reddy, P. K., Lange, P. H.: Coexisting adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for bladder cancer.Urology, 30, 100 (1987).PubMedCrossRefGoogle Scholar
  18. 18.
    Liskow, A. S., Neugut, A. I., Benson, M., Olsson, C. A., Birkhoff, J., Chang, C. H.: Multiple primary tumors in association with prostatic cancer.Cancer, 59, 380 (1987).PubMedCrossRefGoogle Scholar
  19. 19.
    Lynch, H. T., Larsen, A. L., Magnuson, C. W., Krush, A. J.: Prostate carcinoma and multiple primary malignancies: Study of a family and 109 consecutive prostate cancer patients.Cancer, 19, 1891 (1966).PubMedCrossRefGoogle Scholar
  20. 20.
    Berg, J. W.: The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, and myeloma.J. Natl. Cancer Inst., 38, 714 (1967).Google Scholar
  21. 21.
    Peller, S.: Carcinogenesis as a means of reducing cancer mortality.Lancet, 2, 552 (1936).CrossRefGoogle Scholar
  22. 22.
    Liskow, A. S., Romas, Ozzello, L., Suarez, R., Veenama, R., Chang, C. H.: Multiple primary tumors in association with prostate cancer.Cancer, 54, 2549 (1984).PubMedCrossRefGoogle Scholar
  23. 23.
    Kantor, A. F., McLaughlin, J. K.: Second cancer following cancer of the urinary system in Connecticut, 1935–1982.Natl. Cancer Inst. Monogr., 68, 149 (1985).PubMedGoogle Scholar
  24. 24.
    Kleinerman, R. A., Lieberman, J. V., Frederic, P. L.: Second cancer following cancer of the male genital system in Connecticut, 1935–1982.Natl. Cancer Inst. Monogr., 68, 139 (1985).PubMedGoogle Scholar
  25. 25.
    Oesterlind, A., Roth, M., Prenner, A.: Second cancer following cancer of the male genital system in Denmark, 1943–1980.Natl. Cancer Inst. Monogr., 68, 341 (1985).Google Scholar
  26. 26.
    Dieckmann, K. P., Boeckmann, W., Brosig, W., Jonas, D., Bauer, H. W.: Bilateral testicular germ cell tumors. Report of nine cases and a review of the literature.Cancer, 57, 1254 (1986).PubMedCrossRefGoogle Scholar
  27. 27.
    Kantor, A. F., McLaughlin, J. K., Curtis, R. E., Flannery, J. T., Fraumeni, J. F.: Risk of second malignancy after cancer of the renal parenchyma, renal pelvis, and ureter.Cancer, 58, 1158 (1986).PubMedCrossRefGoogle Scholar
  28. 28.
    Greenberg, R. S., Rustin, E. D., Clark, W. S.: Risk of genitourinary malignancy after cancer of the prostate.Cancer, 61, 369 (1988).CrossRefGoogle Scholar
  29. 29.
    Wegner, H. E. H.: Multiple primary cancers in urologic patients: Audit of a 19-year experience in Berlin and review of the literature.Urology, 39, 231 (1992).PubMedCrossRefGoogle Scholar
  30. 30.
    Greven, K. M., Spera, J. A., Solin, L. J., Whittington, R., Wein, A. J., Hanks, G. E.: Secondary malignant neoplasms in patients with bladder carcinoma.Urology, 39, 204 (1992).PubMedCrossRefGoogle Scholar
  31. 31.
    Wegner, H. E. H., Bornhöft, G., Dieckmann, K. P.: Renal-cell cancer and concomitant transitional-cell cancer of the renal pelvis in the same kidney—Report of four cases and review of the literature.Urol. Int. (in press, 1993).Google Scholar
  32. 32.
    Konski, A., Rubin, P., DiSantagnese, P. A., Mayer, E., Keys, H., Cocket, A., Frank, I., Davis, R., Lush, C.: Simultaneous presentation of adenocarcinoma of the prostate and transitional cell carcinoma of the bladder.Urology, 37, 202 (1991).PubMedCrossRefGoogle Scholar
  33. 33.
    Koumi, T., Nishida, H., Saeki, H., Miyagawa, I., Matsui, K.: Prostatic cancer combined with bladder cancer, 6 case reports.Nishinihon J. Urol., 52, 639 (1992).Google Scholar
  34. 34.
    Talamini, R., Franceschi, S., Dal Bo, V., Monfardini, S.: Pattern and determinants diagnostic interval in cancers of the prostate, bladder, and kidney.Tumori, 77, 350 (1991).PubMedGoogle Scholar
  35. 35.
    Giaddipati, J., Ahmed, T., Friedland, M.: Prostatic and bladder cancer in the elderly.Clin. Geriatr. Med., 3, 649 (1987).Google Scholar
  36. 36.
    Jensen, O. M., Knudsen, J. B., Sorensen, B. L.: Second cancer following cancer of the urinary system in Denmark 1943–1980.Natl. Cancer Inst. Monogr., 68, 349 (1985).PubMedGoogle Scholar
  37. 37.
    Silverman, D. T., Hartge, P., Morrison, A. S., Devesa, S. S.: Epidemiology of bladder cancer.Hematol. Oncol. Clin. North Amer., 6, 1 (1992).Google Scholar
  38. 38.
    Baxter, P. J., White, W. G., Barnes, G. M.: Bladder cancer in car workers.Lancet, 134, 377 (1977).CrossRefGoogle Scholar
  39. 39.
    Bitterman, W. A., Farhadian, H., Samra, C. A., Lerner, D., Amoun, H., Krapf, D., Makov, U. E.: Environmental and nutritional factors significantly associated with cancer of the urinary tract among different ethnic groups.Urol. Clin. North Amer., 18, 501 (1991).Google Scholar
  40. 40.
    Cohen, S. M., Johansson, S. L.: Epidemiology and etiology of bladder cancer.Urol. Clin. North Amer., 19, 421 (1992).Google Scholar
  41. 41.
    Petersen, R. O.: Urologic Pathology. J. B. Lippincott Company, Philadelphia 1992, pp. 603–609.Google Scholar
  42. 42.
    Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., Walsh, P. C.: Mendelian inheritance of familial prostate cancer.Proc. Natl. Acad. Sci., 89, 3367 (1992).PubMedCrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó 1994

Authors and Affiliations

  • H. E. H. Wegner
    • 1
  • T. Meier
    • 1
  • R. Klän
    • 1
  • K.-P. Dieckmann
    • 1
  1. 1.Urologische Klinik, Universitätsklinikum SteglitzFreie Universität BerlinBerlinGermany

Personalised recommendations